SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc is trending amid polarized reactions to its latest earnings, which showcased robust growth but were overshadowed by soft Q1 guidance and mounting regulatory scrutiny and legal challenges concerning its GLP-1 weight loss drugs. The community is sharply divided between expectations of a short squeeze due to high short interest and deep concerns over the company's ongoing legal and regulatory pressures.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following a strong revenue report for its Anktiva cancer treatment, igniting fervent community discussion about an impending short squeeze as high short interest clashes with growing bullish sentiment and ambitious price targets. The community is actively celebrating the company's potential as a transformative leader in oncology, with widespread speculation around its global commercial rollout.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending as investors anticipate an 18th consecutive beat-and-raise and potential GAAP profitability in its upcoming earnings, leveraging its AI marketing cloud and OpenAI partnership. While many see it as undervalued, the stock is facing significant headwinds from a broader software sector sell-off, alongside community speculation about unusual bot activity inflating its trending presence.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending after a sharp market sell-off, driven by concerns that Anthropic's new AI tool for COBOL modernization threatens IBM's legacy services. However, a strong counter-narrative suggests this is an overblown reaction, as many highlight IBM's existing AI solutions and established partnership with Anthropic, sparking a debate on AI's true disruptive power in enterprise IT.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

ANPA is trending due to news of its acquisition of TikTok icon Khaby Lame's core company, driving significant speculative interest and comparisons to other volatile low-float stocks. The community is split between anticipating explosive gains from this partnership and raising strong concerns about the company's low revenue, rapidly expanding market cap, and potential share dilution from the deal.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense is trending as investors react to its recent robust earnings beat and new contract awards across hypersonics, drones, and satellite defense, fueling community discussion around its strong market position amid heightened global tensions and anticipated long-term defense spending.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is actively discussed following its significant collaboration with Astellas Pharma on a prostate cancer immunotherapy and encouraging Phase 1 trial results for VIR-5500, driving analyst upgrades and community speculation about a potential short squeeze amidst ongoing accumulation.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending following a strong Q4 earnings beat and robust 2026 guidance, propelled by its essential role in providing power for the rapidly expanding AI data center market, which has driven numerous analyst upgrades. Community discussion centers on the company's massive backlog and bullish momentum, though concerns about its high valuation and volatility persist among some investors.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending as investors balance a reported Q4 revenue miss and net loss against a bullish earnings call that confirmed its strategic pivot to high-performance computing (HPC) data centers with fully funded, on-schedule projects for major hyperscalers. The community is actively discussing the company's re-rating potential from a Bitcoin miner to a core AI infrastructure play, bolstered by a new "Overweight" rating and $38 price target from Morgan Stanley.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending amidst an immediate leadership change as its co-founder steps back into the CEO role to steer the company's AI transformation, intensifying community discussion on the software sector's resilience against AI disruption following its latest earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Allogene Therapeutics, Inc. $ALLO Shares Acquired by Aberdeen Group plc

Aberdeen Group plc boosted its holdings in Allogene Therapeutics, Inc. (NASDAQ:ALLO - Free Report) by 82.4% during the 3rd quarter, according to the company in its most recent filing with the...

Allogene Therapeutics (NASDAQ:ALLO) Raised to "Hold" at Wall Street Zen

Wall Street Zen upgraded shares of Allogene Therapeutics from a "sell" rating to a "hold" rating in a report on Sunday...

Allogene Therapeutics Teases April ALPHA3 Data as cema-cel Targets MRD+ LBCL in Remission

Allogene Therapeutics (NASDAQ:ALLO) Chief Medical Officer Zach Roberts said the company expects to report initial data in April from its ALPHA3 study, a frontline consolidation trial evaluating its...

Allogene Therapeutics (NASDAQ:ALLO) Cut to "Sell" at Wall Street Zen

Wall Street Zen cut Allogene Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

Are Medical Stocks Lagging  Allogene Therapeutics (ALLO) This Year?

Here is how Allogene Therapeutics (ALLO) and McKesson (MCK) have performed compared to their sector so far this year.

Rapid Innovation is Reshaping Oncology: Stocks in Focus

Rapid advances in immunotherapy, targeted drugs & artificial intelligence-driven research are reshaping oncology, spotlighting select cancer stocks to watch now.

Insider Selling: Allogene Therapeutics (NASDAQ:ALLO) CEO Sells 95,269 Shares of Stock

Allogene Therapeutics, Inc. (NASDAQ:ALLO - Get Free Report) CEO David Chang sold 95,269 shares of the business's stock in a transaction on Monday, February 2nd. The stock was sold at an average price...

Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?

Here is how Allogene Therapeutics (ALLO) and Alzamend Neuro, Inc. (ALZN) have performed compared to their sector so far this year.

Insider Selling: Allogene Therapeutics (NASDAQ:ALLO) EVP Sells 26,269 Shares of Stock

Allogene Therapeutics, Inc. (NASDAQ:ALLO - Get Free Report) EVP Zachary Roberts sold 26,269 shares of the company's stock in a transaction dated Wednesday, January 21st. The stock was sold at an...

Here is how Allogene Therapeutics (ALLO) and AN2 Therapeutics, Inc. (ANTX) have performed compared to their sector so far this year.

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, David M. Tanen, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.

Allogene Therapeutics Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Ahead of earnings, sentiment is split between blowout AI growth and concerns around macro pressure, positioning, and post-ER volatility. How do you see it playing out?

Current Price	$2.16
Prev Close	$2.08
Open	$2.10
Dividend Yield	0.00%
50-Day Moving Average	$1.62
Beta	1.55
Avg. Volume	6.32M
PE Ratio	-2.12

52-Week High	$2.32
52-Week Low	$0.8621
Market Capitalization	$467.44M
EPS (Annual)	-$1.32
Price to Book	1.47
Revenue Per Employee	$96.07

ALLO
Allogene Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALLO News

ALLOAllogene Therapeutics Inc